Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- New Way To Ascertain Head And Neck Cancer Stages Developed By Indian Researcherson February 2, 2020 at 1:44 am
New method developed by researchers to determine cancer stages Blood tests can find early stages of cancer Effective in neck and head cancers and oral cancers One of the main methods to determine the ...
- Detecting the risks of prostate cancer with cutting-edge geneticson February 1, 2020 at 9:00 pm
For years, doctors have relied upon well-studied factors to identify patients who are at higher risk for prostate cancer: older age, African American race, family history, elevated prostate blood test ...
- Rod Stewart inspired pal Jimmy Tarbuck to take cancer test after 'brave fight'on February 1, 2020 at 8:30 pm
The legendary TV comic revealed he will get checked out for prostate cancer the day after he turns 80 this week.
- These Start-Ups Are Racing to Help Doctors Detect Cancer Early With a Simple Blood Teston February 1, 2020 at 3:47 pm
Getting a blood test to screen for cancer in the earliest stages might seem like a pipe dream. But a group of biotech entrepreneurs say they’re close to making it a reality. If Gabriel Otte’s start-up ...
- Mutation's role in blood cancers revealed by ideal team-upon January 31, 2020 at 1:38 pm
"I'm a hematological oncologist—I think a lot about blood cancer—so this caught my attention right away ... ASO therapy has been effective in combating other diseases resulting from defective RNA ...
- University of Pennsylvania researchers nab grant for CAR-T prostate cancer teston January 31, 2020 at 8:05 am
The University of Pennsylvania, which has helped pioneer cell therapy approaches to blood cancers, has nabbed an ACGT grant to help battle solid tumors. The research team has been handed a $500,000 ...
- Researchers develop ultasensitive blood test to predict recurrence of gastric cancerson January 28, 2020 at 6:59 am
Researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, developed a blood test that can predict recurrence of gastric cancer in patients after ...
- Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agenton January 28, 2020 at 2:17 am
Compared with other heavy metal elements (e.g., Ag, Cd) that are commonly used in the laboratory synthesis of NPs, Pt NPs that are autologously synthesized in a patient blood can be directly applied ...
- Blood Test Accurately Detects Multiple GI Cancerson January 24, 2020 at 12:29 pm
"Blood tests that can identify cancer in asymptomatic individuals, particularly GI cancers that can be difficult to detect in early stages, could change cancer diagnostics by making it easier to ...
- Blood test could lead to earlier detection of gastrointestinal cancerson January 24, 2020 at 11:46 am
An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various stages, according to study results presented at ...
via Bing News